Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lawrence

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) InhibitorHeather J Finlay, Ji Jiang, Richard Rampulla, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
PK/PD Disconnect Observed with a Reversible Endothelial Lipase InhibitorJon J Hangeland, Lynn M Abell, Leonard P Adam, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
Journal of Medicinal Chemistry|February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisXiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Science Translational Medicine|October 25, 2023
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunityMichael Wichroski, Joseph Benci, Si-Qi Liu, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Nature Methods|January 31, 2015
Orchestrating high-throughput genomic analysis with BioconductorWolfgang Huber, Vincent J Carey, Robert Gentleman, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
Science Translational Medicine|June 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgeryShun Hirayama, Yana Al-Inaya, Michael E Bryan, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) InhibitorHeather J Finlay, Ji Jiang, Richard Rampulla, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
PK/PD Disconnect Observed with a Reversible Endothelial Lipase InhibitorJon J Hangeland, Lynn M Abell, Leonard P Adam, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
Journal of Medicinal Chemistry|February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisXiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Science Translational Medicine|October 25, 2023
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunityMichael Wichroski, Joseph Benci, Si-Qi Liu, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Nature Methods|January 31, 2015
Orchestrating high-throughput genomic analysis with BioconductorWolfgang Huber, Vincent J Carey, Robert Gentleman, et al.
Pageof 16